Switzerland-based Ypsomed is putting down roots in Holly Springs with a hefty $195.4 million investment, marking its first manufacturing foray into North America. This expansion not only broadens the company's reach but also promises to create 62 jobs in the local economy, bringing its renowned injection system technology for self-administered liquid medicine closer to its customer base across the pond.
Ypsomed's CEO, Simon Michel, highlighted the strategic value of the Holly Springs site, emphasizing its central industry location and strong community support. "Establishing our new production site in the United States marks an important milestone in Ypsomed’s global growth strategy," Michel told the Wake County news release. Simon Michel noted the cooperative local authorities and close proximity to top-tier universities as instrumental for Ypsomed's projected growth.
The move has been warmly received by local officials. Wake County Board Chair, Susan Evans, expressed her excitement over Ypsomed's choice, citing not just the 62 new jobs but also the anticipated $195.4 million investment that reflects positively on the strength and allure of the local economy. Mayor Sean Mayefskie of Holly Springs particularly heralded the diversity Ypsomed will bring to the township's life sciences portfolio, remarking on the critical supplies the company will contribute to the production of life-saving medications in Holly Springs. "This announcement brings an expansion in the life science offerings in Holly Springs, diversifying the types of companies located here," Mayefskie stated in the Wake County news release.
With a vision setting them firmly in the pulse of the Triangle's bustling life sciences community, Ypsomed's management eyes are the rapidly evolving self-injectable market with optimism. "The self-injectable market is a quickly evolving and expanding market," said Christopher Chung, CEO of the Economic Development Partnership of North Carolina, emphasizing Ypsomed's role within this dynamic sector. Noting the importance of such an addition to the state's life sciences landscape, Chung's statement reflects the broader belief in Ypsomed's potential impact, as highlighted in the Wake County announcement.
Ypsomed's selection of THE YIELD Holly Springs, a purpose-built life science campus developed by Crescent Communities, as the site for their 110,000 square foot manufacturing operation brings a tangible sense of anticipation to the area. The company’s facility is slated to be operational by the end of 2027, embodying the fruition of efforts by various partners, including the Capital Area Workforce Development Board, Duke Energy, and Wake Technical Community College, who all played a part in attracting the firm to Wake County.
